Brokerage firm Goldman Sachs has upgraded India to "overweight" on Monday, November 10, 13 months after downgrading its view to "neutral" back in October...
Morgan Stanley has initiated coverage on India's four largest pharmaceutical companies by market capitalisation — Sun Pharmaceutical Industries, Lupin, Dr. Reddy's Laboratories (DRL), and...